FORBES: Hydroxychloroquine–Number Of Prescriptions Explodes In France
Alex Ledsom May 10, 2020, 09:00am EDT
Despite the warnings around taking hydroxychloroquine to combat the symptoms of COVID-19, prescriptions in France have increased by as much as 7,000% in certain parts of the country since the pandemic began.
As reported by La Provence, a study looking at the 466 million French prescriptions written since the pandemic began in France, show a huge spike in doctors prescribing the drug. In the last week of March, for instance, over 10,000 people were prescribed hydroxychloroquine in Marseille alone. [...]
In France and the U.S., the use of hydroxychloroquine has been fraught between those who think the risks are small enough to warrant widespread use and those who think that more research is required before widespread prescription.
Following research conducted in China, a French doctor, Didier Raoult–head of the IHU, the Institute of Infectious Diseases in Marseille–claimed at the beginning of March that he had successfully treated patients suffering from coronavirus with the drug. Hydroxychloroquine is an anti-malarial drug also used to treat people suffering from lupus. It is sold under its trader name of Plaquénil in France.
HCQ now a Global Treatment for COVID
Italy Goes All In On HCQ
Costa Rica prescribing HCQ nationwide
Turkish company develops hydroxychloroquine drug
Avanço: Hospital no Piauí cura pessoas da covid-19 e esvazia UTIs com uso de cloroquina
10 de maio de 2020 às 09:05